P28 Impact of FDA Expedited Review Programs on New Drug Approval Time
Abstract
Authors
S. Ronnebaum D. Smith M. Andrawes
S. Ronnebaum D. Smith M. Andrawes
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now